Parallel bond model. by Yanan Sun (316649)

“…The results show that the peak strength, modulus of elasticity and longitudinal wave velocity of the sandstone produced a decrease with the increasing degree of freeze-thaw erosion. …”

Meso-parameters of numerical simulation. by Yanan Sun (316649)

“…The results show that the peak strength, modulus of elasticity and longitudinal wave velocity of the sandstone produced a decrease with the increasing degree of freeze-thaw erosion. …”

The simulated freeze-thaw cycle process. by Yanan Sun (316649)

“…The results show that the peak strength, modulus of elasticity and longitudinal wave velocity of the sandstone produced a decrease with the increasing degree of freeze-thaw erosion. …”

Robust chain-length specific reductions in intermediate chain phospholipids in peroxisomal mutant larvae. by Michael F. Wangler (21526595)

POm shows pronounced response disparity to active and passive whisker stimuli. by Anton Sumser (21021061)

“…Rate increase: 4/11 neurons, rate decrease: 1/11 neurons (light gray), non-significant: 6/11 neurons. …”

Path regulates glial proliferation via the mTOR-S6K pathway. by Qian Dong (414788)

Effects of cell-type specific h- and m-adaptation gains on SLE rates. by Scott Rich (9873638)

“…Results as in Panel <b>A</b>. Increasing increases SLE rate, while increasing decreases it. …”

Effect of NNK on 1p-Enh activity and CYP4B1 expression. by Li Dai (159381)

“…<p><b>(A)</b> Luciferase reporter assays showed a significant increase in 1p-Enh activity in AC-16 and Beas-2B cells following exposure to NNK for 24h. …”

Minimal data sets. by Razia Rashid Rahil (22772495)

“…Moreover, GW4869 (SMase inhibitor) and evogliptin significantly reduced SMase activity in sphingomyelin (SM)-induced VSMCs as compared to both P_i and SM only-treated groups. …”

pone.0337200.t001 - by Razia Rashid Rahil (22772495)

“…Moreover, GW4869 (SMase inhibitor) and evogliptin significantly reduced SMase activity in sphingomyelin (SM)-induced VSMCs as compared to both P_i and SM only-treated groups. …”

<i>Wigglesworthia</i> and <i>Sodalis</i> density in mated dsCPT1(treatment) compared to dsGFP (control) treated Gmm at the end of their 4^th GC. by Brian L. Weiss (7225103)

Female regression coefficients for regression #3 across development in set size = 2 and set size = 4. by Juliana Chase (20469427)

Spectral-domain optical coherence tomography (SD-OCT) images taken from a 72-year-old female patient with neovascular age-related macular degeneration (nAMD) who received ranibizum... by Zheyao Gu (20910794)

Flowchart of the study. by Flavia Furlaneto (20161022)

“…<i>Granulicatella adiacens</i> decreased significantly after the probiotic therapy, while <i>Saccharibacteria</i> (TM7) spp., <i>Solobacterium moorei</i>, and <i>Catonella morbi</i> increased significantly. …”

Changes in relative abundance of genera in both therapeutic groups. by Flavia Furlaneto (20161022)

“…In contrast, <i>Schaalia</i> increased in the placebo and decreased in the probiotic group by 31%.…”

Hypoxia-induced pulmonary remodeling. by Yuko Shirota (4351867)

“…Group1 mice showed a significant decrease in normal but increase in fully remodeled arterial walls. …”

Strategy parameters across development for female mice in set size = 2 and set size = 4 from winning computational model. by Juliana Chase (20469427)

Initial assessment of βHB treatment effects. by Noam H. Sander (13977976)

“…This increase was significantly reduced in the βHB group (p = 0.0210). …”

Effect of hypoxia on hepatocyte injury in NAFLD model mice. by Meiyuan Tian (22311505)

The Type I JAKinib, ruxolitinib, promotes pJAK1 and pJAK2 phosphorylation in MSCs from salivary glands. by Ilya Gurevic (1326786)

“…(E-G) were performed with replicates (n = 6; 3 SjD and 3 control) of our treatment conditions on the right with a representative western on the left; (E) pJAK1 proportion increased in a dose-dependent manner with increasing ruxolitnib; (F) pJAK2 proportion increased as ruxolitinib dose increased; (G) pSTAT1 decreased in a dose response relationship with increasing ruxolitinib. …”